PT - JOURNAL ARTICLE AU - Faure, Valérie AU - Souris, Marc AU - Wilmet, Arnaud AU - Baudino, Franck AU - Brizo, Albert AU - Malhaire, Christophe AU - Peccaud, François-Xavier AU - Gonzalez, Jean-Paul TI - NEWS-2 Score Assessment of Inpatient Referral during the COVID 19 Epidemic AID - 10.1101/2021.06.10.21254528 DP - 2021 Jan 01 TA - medRxiv PG - 2021.06.10.21254528 4099 - http://medrxiv.org/content/early/2021/06/12/2021.06.10.21254528.short 4100 - http://medrxiv.org/content/early/2021/06/12/2021.06.10.21254528.full AB - Aim To manage patients with suspected coronavirus disease (COVID-19) when they arrive at the hospital emergency department (ED), a clinical severity score is required to quickly identify patients requiring immediate hospital admission and close monitoring. The aim of this study was to evaluate, within the context of the pandemic, the performance of National Early Warning Score 2 (NEWS-2) to anticipate the admission of patients with suspected COVID-19 to a specialised emergency care unit.Methods This retrospective study was conducted on patients presenting at the COVID-19 entrance of the ED of the Vert-Galant private hospital (Paris, France) during the first national pandemic peak from March 20 to April 20, 2020. All patients completed a questionnaire and clinical data and vital signs were recorded. Statistical analysis and modelling were used to estimate the ability of different scores (NEWS-2, qSOFA, CRB-65) to predict hospital emergency admission and/or early COVID-19 diagnosis.Results NEWS-2, with a cut off value of 5, predicted hospital admission with 82% sensitivity, 98% specificity and an area under the curve (AUC) of 96%. NEWS-2 was superior to qSOFA and CRB-65 scores for predicting hospital admission of COVID-19 patients. Multilinear or logistic regression analysis of clinical data did not improve this result.Conclusion NEWS-2 is an excellent score to predict hospital admission of COVID-19 patients.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was receivedAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The project (referenced under the number COS-RGDS-2021-05-001-FAURE-V) has been submitted to the members of the Scientific Committee of the GCS Ramsay Sante for Education and Research. The committee has reviewed the following documents: application form for ethical advice on a project research and the synopsis of the study. This study has received a favorable opinion on 05/04/2021 (Numero IORG de Ramsay sante Recherche & Enseignement: IORG0009085; Numero IRB du Conseil d'Orientation Scientifique: IRB00010835). All patients were informed of the data collection by a specific poster in the waiting room and gave their informed consent prior to the recording of vital signs by the TMB. All patients received a letter informing them of the study and gave their informed consent, according to MR004 methodology. All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesDatabase is available on request if confidentiality is ensured.